首页 | 本学科首页   官方微博 | 高级检索  
     


Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studies
Authors:Büchner Thomas,Döhner Hartmut,Ehninger Gerhard,Ganser Arnold,Hasford Jörg  German AML Inter-group
Affiliation:

a Department of Medicine, Hematology and Oncology, University of Münster, Albert-Schweitzer-Strasse 33, D-48129, Münster, Germany

b Department of Medicine, Hematology and Oncology, University of Ulm, Ulm, Germany

c Department of Medicine, Hematology and Oncology, University of Dresden, Dresden, Germany

d Department of Medicine, Hematology and Oncology, Medical University of Hannover, Hannover, Germany

e Department of Medical Biostatistics and Epidemiology, University of Munich, Munich, Germany

Abstract:Most multicenter randomized AML studies use randomizations of patients early or later in complete remission which necessarily occur with exclusions and positive selection of patients included. Since the exclusion criterias are regimen related and do not follow common standards, incomparabilities between treatment results across different studies are produced by these late randomizations. In order to overcome this problem, we here propose a cooperation of studies on the basis of a general up-front randomization with attribution of 10% patients from each study to a common standard arm. A validation of complete treatment strategies according to intent-to-treat against the standard arm and thus also across the studies is provided by this inter-group model which may contribute to accelerate the therapeutic progress in AML.
Keywords:AML studies   Inter-group cooperation   Common standard arm   Up-front randomization
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号